Home > News > Wall Street will resume nanotechnology financing
December 13th, 2007
Wall Street will resume nanotechnology financing
Abstract:
During the last five years, Wall Street has not been active in nanotechnology financing. It has allowed the venture capital companies, without competition, to cherry-pick the elite nanotechnology investment opportunities while leaving many promising nanotechnology ventures to starve financially. Today, with 400+ nanotechnology products in the domestic marketplace, the industry appears credible and the Street's focus may be changing. The planned $100 million Initial Public Offering (IPO) by NanoDynamics, Inc (ND) may change the funding landscape for nanotechnology companies. It's a very important change. The reasons behind the ND IPO's expected success will become clear once you dig through the S-1 Prospectus, understand which specific green and nanotechnology markets ND's new products aim to penetrate and why ND will be profitable in both those markets. "Green Energy and Nanotechnology" is a winning corporate strategy for the next decade. After a successful ND offering, a financing rush will be on and Wall Street should once again become a major player in nanotechnology funding, especially for young and cash-starved nanotechnology companies.
Source:
merinews.com
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||